ReactomeAI is Reactome.org's commercial spin-off, offering bespoke drug and target pathway curation, deploying AI to identify, map, and repurpose drug candidates and therapeutic targets, advancing the Reactome open-source knowledgebase for proprietary drug insights and discovery.
I'm looking for
8 months ago
ReactomeAI is seeking funding and commercial partners to bring systems biology-driven drug repurposing and pipeline intelligence to biopharma at every scale — accelerating discovery, reducing attrition, and unlocking new therapeutic value from existing pathway knowledge.
About
I am a tenured Professor at St. John's University's College of Pharmacy and Health Sciences and Adjunct Professor at NYU Grossman School of Medicine. A molecular biologist and translational bioinformatician/biocurator with a Ph.D. in Oncological Sciences (University of Utah), I completed a Postdoc at Memorial Sloan Kettering Cancer Center. I have spent over two decades bridging bench science and scalable digital infrastructure. As a long-standing curator, editor, and contributor to the Reactome Pathway Knowledgebase, I am part of the Leadership Team deploying ReactomeAI — an initiative to transform open biomedical pathway knowledge into intelligent, AI-driven tools for clinical diagnostics, drug discovery, and precision medicine.